Background: Calcitonin gene-related peptide (CGRP), implicated in migraine pain, also possesses bone anabolic properties, which leads to the possibility that monoclonal antibodies targeting CGRP (anti-CGRPs) might increase the risk of bone density abnormalities.
Objective: The objective of this study was to explore bone mineral density abnormalities in a cohort of migraine patients treated with anti-CGRPs.
Methods: This was a single-center, cross-sectional, cohort study including migraine patients who underwent a densitometry assessment during anti-CGRP treatment.
() is a bacterium found in the digestive tract of some flies. A few cases of bacteremia by are described in the literature. We present the case of a patient with chronic leg ulcer and poor hygienic and social conditions, who presented with bacteremia from .
View Article and Find Full Text PDF